Spinal ependymoma, MYCN-amplified is a rare spinal ependymal tumor that has been recently characterized and included as a new entity in the 2021 WHO Classification of CNS Tumors (WHO Classification of Tumours Editorial Board, 2021). The gene discussed is MYCN; the disease is central nervous system neoplasm.